In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo
Annals of Internal Medicine · 2024
DOI: 10.7326/j24-0026 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Eric R Bates. Beteiligte Einrichtung: University of Michigan, Ann Arbor, Michigan, USA (E.R.B.). Hauptthemen laut MEDLINE: Colchicine, Diabetes Mellitus, Type 2, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
SOURCE CITATION: Roubille F, Bouabdallaoui N, Kouz S, et al. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47:467-470. 38181203.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Michigan, Ann Arbor, Michigan, USA (E.R.B.).
Zitieren
APA
Bates, E. R. (2024). In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Annals of Internal Medicine. https://doi.org/10.7326/j24-0026
Vancouver
Bates ER. In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Annals of Internal Medicine. 2024. doi:10.7326/j24-0026
BibTeX
@article{Bates2024,
author = {Bates, Eric R},
title = {In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/j24-0026}
}
EUVIMED